Late-breaking clinical trials presented at the 2005 and 2006 annual scientific meetings of
the ACC, AHA, and European Society of Cardiology, as well as selected other data, were …

The process of guideline development for management of patients with acute myocardial
infarction (AMI) has undergone substantial evolution since the inaugural publication entitled “…

… versus intergroup difference was 5.00 for men (p < .01) and 4.95 for women (p < .01) in
science. The mean ratio was 4.91 for men (p < .01) and 4.78 for women (p < .01) in mathematics. …

Background Data are lacking on the long-term effect on cardiovascular events of adding
sitagliptin, a dipeptidyl peptidase 4 inhibitor, to usual care in patients with type 2 diabetes and …

… significantly correlated with 1-year mortality in patients undergoing primary PCI for STEMI
(relative risk equals 1.08 for each 30-minute delay from symptom onset to balloon inflation; P …

Myocardial infarction is a major cause of death and disability worldwide. Coronary atherosclerosis
is a chronic disease with stable and unstable periods. During unstable periods with …

We present constraints on cosmological parameters from the Pantheon+ analysis of 1701
light curves of 1550 distinct Type Ia supernovae (SNe Ia) ranging in redshift from z= 0.001 to …

… % lower risk of death (P=0.128) but a significant 12% lower risk of death or hospitalization
for any reason (P=0.002) and 24% fewer hospitalizations for heart failure (P=0.002). Dizziness …

… This can be simulated by adding to p oij an increment in p ij proportional to e pij dt.
Secondly, the plastic strain increment diminishes the effect of p oij on conditions after the …

… 66.1%, P=0.007), but the prespecified level for significance (P≤0.005 for both assessments
or P≤0.0025 for either) was not met. The rate of rehospitalization for heart failure or death …